RxDoctor Payments Data

Kunal Saigal, MD

Therapeutic Radiology · Sarasota, FLNPI 1073772067

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,000 of the $7,908 with a category attached, or 75.9%. Elekta, Inc. accounts for 76.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $3,184 and has fallen 77.1% since, to $730 in 2025.

$7,908in general payments, 2019–2025

Across 30 payments — averaging $263.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elekta, Inc.$6K
  • Brainlab, Inc.$533
  • Samsung HME America, Inc.$184
  • Medtronic$161
  • Boston Scientific$151
  • Hologic Sales And Service, LLC$147
  • plus $670 from 12 others
$9,506in research payments, 2019–2025

Across 1 payment — averaging $9506.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$10K

What the payments were for

  • Consulting fees$6,00076%
  • Travel & lodging$4235%
  • Food & beverage$1,48519%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few therapeutic radiology providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,693,281
Medicare patients
619
Services billed
12,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Silodosin48$1,911
Lidocaine Hcl ViscousLidocaine Hcl24$616
SsdSilver Sulfadiazine28$297
Tamsulosin Hcl17$176
Levetiracetam14$152
Prochlorperazine Maleate12$142
Meloxicam27$101
Ciprofloxacin Hcl14$61
Tramadol Hcl13$37

Paid to pharmacies, not to this prescriber.

Other therapeutic radiology in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →